Davenport & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
394
-33
| -8% | -$17.3K | ﹤0.01% | 1144 |
|
|
2025
Q1 | $271K | Buy |
+427
| New | +$271K | ﹤0.01% | 1011 |
|
|
2024
Q4 | – | Sell |
-430
| Closed | -$452K | – | 1165 |
|
|
2024
Q3 | $452K | Buy |
430
+60
| +16% | +$63.1K | ﹤0.01% | 837 |
|
|
2024
Q2 | $389K | Sell |
370
-82
| -18% | -$86.2K | ﹤0.01% | 858 |
|
|
2024
Q1 | $435K | Buy |
452
+78
| +21% | +$75.1K | ﹤0.01% | 826 |
|
|
2023
Q4 | $328K | Sell |
374
-3
| -0.8% | -$2.64K | ﹤0.01% | 862 |
|
|
2023
Q3 | $310K | Sell |
377
-2,601
| -87% | -$2.14M | ﹤0.01% | 849 |
|
|
2023
Q2 | $2.14M | Sell |
2,978
-939
| -24% | -$675K | 0.02% | 370 |
|
|
2023
Q1 | $3.22M | Sell |
3,917
-1,015
| -21% | -$834K | 0.03% | 314 |
|
|
2022
Q4 | $3.56M | Sell |
4,932
-90
| -2% | -$64.9K | 0.03% | 295 |
|
|
2022
Q3 | $3.46M | Sell |
5,022
-49
| -1% | -$33.8K | 0.03% | 283 |
|
|
2022
Q2 | $3M | Buy |
5,071
+28
| +0.6% | +$16.6K | 0.02% | 309 |
|
|
2022
Q1 | $3.52M | Buy |
5,043
+243
| +5% | +$170K | 0.02% | 312 |
|
|
2021
Q4 | $3.03M | Buy |
4,800
+2,121
| +79% | +$1.34M | 0.02% | 330 |
|
|
2021
Q3 | $1.62M | Buy |
2,679
+2,141
| +398% | +$1.3M | 0.01% | 429 |
|
|
2021
Q2 | $300K | Buy |
+538
| New | +$300K | ﹤0.01% | 786 |
|